| Identification | Back Directory | [Name]
(11beta,16alpha)-9-fluoro-11-hydroxy-17,21-[(1-methoxypentylidene)bis(oxy)]-16-methylpregna-1,4-diene-3,20-dione | [CAS]
1062-64-2 | [Synonyms]
9-Fluoro-11β-hydroxy-17,21-[(1-methoxypentylidene)bis(oxy)]-16α-methylpregna-1,4-diene-3,20-dione
(11β,16α)-9-Fluoro-11-hydroxy-17,21-[(1-methoxypentylidene)bis(oxy)]-16-methyl-pregna-1,4-diene-3,20-dione
(11beta,16alpha)-9-fluoro-11-hydroxy-17,21-[(1-methoxypentylidene)bis(oxy)]-16-methylpregna-1,4-diene-3,20-dione
(11β,?16α)?-9-?Fluoro-?11-?hydroxy-?17,?21-?[(1-?methoxypentylidene)?bis(oxy)?]?-?16-?methyl-pregna-?1,?4-?diene-?3,?20-?dione | [EINECS(EC#)]
213-898-6 | [Molecular Formula]
C28H39FO6 | [MOL File]
1062-64-2.mol | [Molecular Weight]
490.604 |
| Hazard Information | Back Directory | [Uses]
(11beta,16alpha)-9-fluoro-11-hydroxy-17,21-[(1-methoxypentylidene)bis(oxy)]-16-methylpregna-1,4-diene-3,20-dione is an intermediate in synthesizing Dexamethasone Valerate (D298870), an impurity of Dexamethasone (D298800), which is a glucocorticoid that is used as an anti-inflammatory agent. Dexamethasone regulates T cell survival, growth, and differentiation. Dexamethasone inhibits the induction of nitric oxide synthase. |
|
|